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Sedimentation equilibrium experiments were performed on the cryo -light chain protein that had been preequilibrated in the no-salt buffer and run at 6000 and 12 000 rpm at 20°C (analysis could not be performed at 4°C because of protein precipitation at higher concentrations). Sedimentation equilibrium centrifugation analysis with a selfassociation model revealed that the mean molecular mass of the cryo protein in the absence of salt at 20°C was M r 60 000. The sedimentation data were consistent with a mixture of 70% dimers and 30% tetramers.
Early studies investigating the mechanisms of temperature-and concentration-dependent cryoprecipitation have shown that low temperatures change the intramolecular environment of the protein, particularly with certain aromatic residues (4 ). It is possible that there are both salt-and temperature-dependent changes at 20°C and that only the salt-dependent changes in polymerization are detected by either sedimentation equilibrium or by the apparent M r measured by gel filtration at 4°C. Low salt accurately reflects the presence of trimers and hexamers that would form a cryoprecipitate at the higher concentration of light chain protein found in undiluted urine stored at 4°C. The sodium concentration in urine can vary considerably, and we did not ascertain the sodium in the urine of the cryo patient. It is noteworthy, however, that the control light chain did not show any salt-dependent changes in relative molecular mass, unlike the cryo protein.
It is likely that several physicochemical factors contributed to urine cryoglobulin formation in this patient, including the immunoglobulin light chain protein sequence, resulting from the inherent diversity in the variable regions of immunoglobulins, and the concentration, because the protein had to be diluted substantially to prevent precipitation on the gel-filtration column at 4°C. In addition, there was no evidence of clinical symptoms related to the urine cryo at physiologic temperature. The urine remained a clear liquid at room temperature and 37°C and showed complete gel formation only at 4°C. However, because we do not have data to confirm the role of these various factors, the extent to which these may have contributed to cryo formation in this patient remains speculative. † These authors contributed equally to this work. V617F singlebase sequence variant, observed in a broad range of Philadelphia chromosome-negative myeloproliferative diseases (MPDs) (3 ), to test this method of detection of somatic point variants. We used the molecular beacon to specifically detect the JAK2 V617F mutant allele and the LNA oligonucleotide to limit amplification of the wild-type JAK2 sequences (see Fig. 1 in the Data Supplement that accompanies the online version of this letter at http://www.clinchem.org/content/ vol52/issue7). With this method, we detected very small quantities of mutant alleles in tubes containing the homozygous JAK2 V617F mutant cell line (HEL cell line) mixed with various amounts of wild-type cells and in clinical specimens containing small amounts of JAK2 V617F mutated cells.
Primers and beacon probe were designed with the freeware MELT-CALC, Ver. 2.0 (http://www. meltcalc.de/). The melting temperature (T m ) of the molecular beacon stems was calculated by use of the Mfold algorithm (http://www. bioinfo.rpi.edu/applications/mfold/ old/dna/form1.cgi), whereas the T m of the LNA was calculated via the Exiqon website (http://lna-tm.com).
We used unique PCR conditions (see Table 1 and experimental conditions in the online Data Supplement) that exploited the combined activities of the molecular beacon and LNA oligonucleotide to produce a fluorescent amplification signal highly specific to the JAK2 V617F DNA target (Fig. 1A) . We tested different concentrations of LNA and found that a concentration of 1000 nM gave the most efficient blocking of the wild-type allele without significant alteration in the detection of the mutated allele ( Fig. 1A ; also see Fig. 3 in the online Data Supplement). In addition, at this concentration, the low residual amount of wild-type allele present at the end of the PCR procedure was not recognized by the molecular beacon probe (Fig. 1A) .
Dominguez and Kolodney (4 ) recommended the use of a mutated Taq polymerase, termed the Stoffel fragment, which lacks the 5Ј-3Ј exonuclease activity, on the basis of their hypothesis that this exonuclease activity would hydrolyze the LNA oligonucleotide and prevent it from blocking primer extension of the wild-type target template. We found, however, that the conventional Taq polymerase included in the commercially available Supermix-UDG (Invitrogen) did not significantly alter the blocking activity of the LNA component.
We tested the quantitative sensitivity of our method with serial dilutions of the HEL cell line DNA mixed with wild-type DNA, and the method was able to detect JAK2 V617F mutated alleles at proportions as low as 0.01% (Fig. 1B) . The efficiency of this PCR was 91.9%, as demonstrated by the slope of the curve. Theoretically, the sensitivity could not be higher because, in a 100% homozygous mutant sample, a starting amount of 100 ng of genomic DNA would contain ϳ34 000 copies (based on a typical amount of 6 pg of DNA per diploid cell) of JAK2 V617F mutant allele, and a diluted sample containing 0.01% of this mutant gene would theoretically represent ϳ3 copies of the target sequence. We are thus very close to the limits of detection of any type of quantitative PCR assay. Of note, these results confirm that complete blocking of amplification of the wild-type allele is not an absolute prerequisite for very good quantitative sensitivity for the mutant allele.
We also compared the sensitivity of our tool with the Amplification Refractory Mutation System (ARMS)-PCR method for JAK2 V617F detection (5 ) . We used ARMS-PCR to test DNAs from 23 patients carrying the JAK2 V617F sequence variant and observed that all results were perfectly concordant with our method. Moreover, 2 patients with clearly positive results by our method showed only a weak signal by ARMS-PCR (data not shown). The great sensitivity as well as the quantitative aspects of our method present 2 advantages: (a) in some cases of positive JAK2 V617F MPD, the variation is limited to small subclones; and (b) small molecules are being developed that specifically target the mutated protein (6 ). Our sensitive assay could be very useful in testing the efficacy of such molecules in the frame of therapeutic trials as well as in daily molecular follow-up.
In summary, we developed a very (A), amplification curves of both mutant and wild-type JAK2 sequences, with and without the use of LNA oligonucleotide. As observed, the variations in JAK2 V617F threshold cycle remain very narrow with the different concentrations of LNA blocking sequence used. Moreover, the wild-type sequence is not detected by the molecular beacon. Shown are curves for mutant DNA plus no (ࡗ), 10 nM (OE), 100 nM (F), and 1000 nM LNA (f); wild-type DNA plus no (छ) and 1000 nM LNA (Ⅺ); and a control containing water and 1000 nM LNA ( ). (B), amplification curves obtained from serial dilutions of homozygous JAK2 V617F mutant allele diluted in wild-type DNA. As observed, a detection limit of 0.01% JAK2 V617F could be reached. sensitive and rapid method that combines the advantages of LNA and molecular beacon technologies. Our tool, which can be used to detect any type of single-base variation, is a simple PCR performed in Ͻ40 min, under universal conditions and in sealed tubes, hence limiting the risk of false positivity and contributing to the high sensitivity offered by our PCR assay.
